PDCD1 and gastric cancer: Herein, these results suggested that PD-1+CD8+ T cells low abundance predicted optimal fluorouracil-based chemotherapeutic responsiveness for patients with TNM Stage III GC, and patients with PD-1+CD8+ T cells high abundance might have a higher risk of chemoresistance.